[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dyne Therapeutics, Inc. (“Dyne” or the “Company”) (NASDAQ: DYN). Such investors are advised to contact Danielle Peyton […]
Tag: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of C3.ai, Inc.
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of C3.ai, Inc. (“C3.ai” or the “Company”) (NYSE: AI). Such investors are advised to contact Danielle Peyton at […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Franklin Resources, Inc.
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Franklin Resources, Inc. (“Franklin” or the “Company”) (NYSE: BEN). Such investors are advised to contact Danielle Peyton at […]
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Paragon 28, Inc.
[ad_1] NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSE: FNA). Such investors are advised to contact Danielle […]
